Ovidiu Chioncel, Beth Davison, Marianna Adamo, Laura E Antohi, Mattia Arrigo, Marianela Barros, Jan Biegus, Kamilė Čerlinskaitė-Bajorė, Jelena Celutkiene, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Christopher Edwards, Gerasimos Filippatos, Antoine Kimmoun, Carolyn S P Lam, Marco Metra, Maria Novosadova, Matteo Pagnesi, Peter S Pang, Piotr Ponikowski, Razvan I Radu, Hadiza Saidu, Karen Sliwa, Adriaan A Voors, Koji Takagi, Jozine M Ter Maaten, Daniela Tomasoni, Gad Cotter, Alexandre Mebazaa
AIMS: To assess the potential interaction between noncardiac comorbidities (NCCs) and the efficacy and safety of high intensity care (HIC) versus usual care (UC) in STRONG-HF trial, including stable patients with improved but still elevated NPs METHODS AND RESULTS: In the trial, 8 NCCs were reported: anemia, diabetes, renal dysfunction, severe liver disease, COPD/asthma, stroke/TIA, psychiatric/neurological disorders, and malignancies. Patients were classified by NCC number (0, 1, 2 and ≥3)...
September 20, 2023: European Journal of Heart Failure